Thus, our findings suggest that early treatment with antioxidants and IL-1 signaling inhibitors may represent potential therapeutic intervention for COVID-19, and that such interventions may also have a role in the recovery phase of the disease. This evidence concerns the gene IL1B and COVID-19.